Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Fujifilm Life Sciences Corporate Venture Capital

Profile, fund size and leaders

Parent Fujifilm HoldingsHQ Tokyo, JapanFounded 2022

Fujifilm Life Sciences Corporate Venture Capital is the corporate venture arm of Fujifilm Holdings, a healthcare company. It was founded in 2022 and is based in Tokyo, Japan. It invests from seed to Series A. Sectors it names: biotech and life sciences.

Commitment by parentS1
JPY 7bn

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsBiotech and life sciences
GeographyGlobal
OfficesTokyo, Japan, Cambridge, United States, Dusseldorf, Germany

Sources: S2 Fujifilm: Fujifilm invests in PhenoVista Biosciences from its Life Sciences CVC fund; S1 GlobeNewswire (Fujifilm): Fujifilm launches life sciences strategic investment fund.

Graphic 1 of 2

Investment stage: Seed to Series A

Sources: S2 Fujifilm: Fujifilm invests in PhenoVista Biosciences from its Life Sciences CVC fund; S1 GlobeNewswire (Fujifilm): Fujifilm launches life sciences strategic investment fund.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeJPY 7bnCommitment by parentStated by the firm or its parentS1

Sources: S1 GlobeNewswire (Fujifilm): Fujifilm launches life sciences strategic investment fund.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 GlobeNewswire (Fujifilm): Fujifilm launches life sciences strategic investment fund.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Tokyo, Japan
Offices

Investment regionsS2S1

LeadersS2

Fujifilm Life Sciences Corporate Venture Capital on LinkedIn

Key facts

FactValueStatusSource
Parent companyFujifilm Holdings (TSE: 4901)Single sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
Founded2022Single sourceS1
HeadquartersTokyo, JapanSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Headline sizeJPY 7bn (Commitment by parent)Single sourceS1
StagesSeed, Series A (inferred from announced rounds)EstimateS2

About Fujifilm Holdings

ItemDetailSource
Listed asTSE: 4901S1
HeadquartersJapanS1

Fund vehicles

VehicleSizeYearSource
Life sciences strategic investment fundJPY 7bn2022S1

Recent rounds

DateCompanyRoundAmountSource
2022-12-14PhenoVista BiosciencesNot statedNot statedS2

Portfolio

Portfolio company named in public sources: PhenoVista Biosciences.S2

Official pages

Read the firm's own pages for current information.

Sources

  1. S1GlobeNewswire (Fujifilm): Fujifilm launches life sciences strategic investment fundParent company
  2. S2Fujifilm: Fujifilm invests in PhenoVista Biosciences from its Life Sciences CVC fundFirm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Fujifilm Life Sciences Corporate Venture Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.